SCHEMBL1247569

SCHEMBL1247569

CCOC(=O)N(c1cccc(F)c1F)c1c(-c2ccc(-c3ccc(CC(=O)O)cc3)cc2)noc1C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
NR1H4 Q96RI1 4/20 0.36
PPARD Q03181 1/20 0.35
PTGIR P43119 1/20 0.35
CACNA1F O60840 1/20 0.35
CACNA1D Q01668 1/20 0.35
CACNA1S Q13698 1/20 0.35
CACNA1C Q13936 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
PTGS2 P35354 2/20 0.34
DGAT1 O75907 1/20 0.34
PTGS1 P23219 1/20 0.34
PDE3A Q14432 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1245270 0.94 KDM4E (0.44) SCN9AKDM4ENPC1NR1H4PPARD
SCHEMBL1247291 0.92 SCN9A (0.41) SCN9AKDM4ENPC1NR1H4PPARD
SCHEMBL1246323 0.88 PPARD (0.39) KDM4ENR1H4PPARDCACNA1FCACNA1D
SCHEMBL1245262 0.86 THRB (0.37) KDM4ENPC1CACNA1FCACNA1DCACNA1S
SCHEMBL1247624 0.86 THRB (0.37) KDM4ENPC1DGAT1
SCHEMBL1245358 0.86 NR1H4 (0.42) SCN9ANR1H4PPARDMAPTPTGS2
SCHEMBL1247323 0.85 NR1H4 (0.46) NR1H4PPARDCACNA1FCACNA1DCACNA1S
SCHEMBL2341053 0.85 LPAR1 (0.42) KDM4ENR1H4PTGIRTP53DGAT1
SCHEMBL1247349 0.85 GPBAR1 (0.39) KDM4ENR1H4PPARDPTGIRCACNA1F
SCHEMBL1246439 0.85 PPARD (0.37) SCN9ANR1H4PPARDMAPTDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462128-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
WO-2011017350-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed